PMID: 9444480Jan 28, 1998Paper

Schizophrenia and glutamatergic transmission

Critical Reviews in Neurobiology
C A Tamminga

Abstract

Schizophrenia is a human brain disease with well-defined symptoms and a lifelong disease course, but without a current biological explanation. Several observations implicate brain glutamatergic abnormalities in the pathophysiology of this illness. This evidence includes both human neurochemical and clinical pharmacologic data. Furthermore the psychotomimetic action of phencyclidine, the noncompetitive NMDA-sensitive glutamate receptor antagonist, suggests the association between human psychosis and NMDA receptor blockade. This paper reviews basic aspects of glutamatergic transmission in animal and human brain with particular attention to its putative role in schizophrenia. Consideration is given to other glutamate-related human brain diseases and their purported mechanisms. Evidence of glutamatergic abnormalities in schizophrenia is critically reviewed, including data using postmortem neurochemistry, in vivo human brain imaging, clinical pharmacology, and animal models. The current theoretical formulations based on these studies are articulated. We propose a "working" glutamate hypothesis of schizophrenia which postulates a diminished glutamatergic transmission in the hippocampal glutamate-mediated efferent pathways and cerebra...Continue Reading

Citations

Mar 21, 2000·Journal of Neuroscience Research·F I Tarazi, R J Baldessarini
Feb 9, 2006·Journal of Neural Transmission·G Ceresoli-BorroniR Schwarcz
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Uriel Heresco-Levy
Jun 9, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kenji HashimotoMasaomi Iyo
Jan 29, 2000·Biological Psychiatry·S M Richardson-BurnsJ H Meador-Woodruff
Aug 7, 2002·European Journal of Pharmacology·Stephen I DeutschJohn Mastropaolo
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·S M TurgeonW W Graves
Dec 14, 2002·Pharmacology, Biochemistry, and Behavior·Eddie N BillingsleaStephen I Deutsch
Apr 2, 2003·Pharmacology, Biochemistry, and Behavior·Laszlo G HarsingGyorgy Levay
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·A J Goudie, J A Smith
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Albert Hung Choy Wong, Hubert H M Van Tol
Mar 17, 2000·Brain Research. Brain Research Reviews·C A TammingaH H Holcomb
Aug 17, 2001·Trends in Neurosciences·R R GainetdinovM G Caron
May 23, 2001·Progress in Neurobiology·N C Danbolt
Mar 26, 2002·Biological Psychology·Naoko ShinozakiSunao Kaneko
Jul 9, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michal Arad, Ina Weiner
Jul 6, 2000·British Journal of Pharmacology·M Bujas-BobanovicS M Dursun
Apr 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R A E HoneyP C Fletcher
Jul 22, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Henry H HolcombCarol A Tamminga
Jan 18, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lin ZhangKenji Hashimoto
Mar 16, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xavier López-GilAlbert Adell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Related Papers

The British Journal of Psychiatry. Supplement
C A Tamminga
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
Kenji Hashimoto, Masaomi Iyo
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
Yukihiro NodaT Nabeshima
© 2021 Meta ULC. All rights reserved